GlaxoSmithKline Pakistan Limited (KASE: GLAXO)
Health Care · Pharmaceuticals · PK
PKRs314.59
+0.03% today · -28.4% 1Y
GlaxoSmithKline Pakistan Limited (KASE: GLAXO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $361.36M.
Over the last twelve months the share price has lost 28.4%, trading between 293.09 and 459.27.
Tweenvest scores GlaxoSmithKline Pakistan Limited across four factors: quality 74/100, value 73/100, growth 76/100, dividend 86/100. Its strongest factor is dividend.
GLAXO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $361.36M
- Revenue (TTM)
- $241.45M
- P/E
- 9.62
- EPS
- 32.69
- Dividend yield
- 6.04%
- Beta (5Y)
- 0.39
- 52-week high
- PKRs459.27
- 52-week low
- PKRs293.09
- Avg volume (3M)
- —
- Shares outstanding
- 318.47M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ASKA Pharmaceutical Holdings Co.,Ltd.TSE: 4886 | $365.48M | ¥2,030.00 | -5.89% |
| Honz Pharmaceutical Co., Ltd.SZSE: 300086 | $364.35M | CN¥5.37 | -14.35% |
| Deva Holding A.S.IBSE: DEVA | $362.23M | TL89.00 | -8.95% |
| Suzhou Fushilai Pharmaceutical Co., Ltd.SZSE: 301258 | $361.87M | CN¥27.40 | +2.20% |
| Qinghai Spring Medicinal Resources Technology Co., Ltd.SHSE: 600381 | $358.37M | CN¥4.20 | +7.97% |
| Solara Active Pharma Sciences LimitedNSEI: SOLARA | $358.23M | Rs714.85 | -3.29% |
| Ind-Swift Laboratories LimitedNSEI: INDSWFTLAB | $356.90M | Rs395.15 | -2.28% |
| Boiron SAENXTPA: BOI | $355.60M | €17.70 | -3.28% |
Figures last refreshed Oct 4, 2026.